Stock Track | Edwards Lifesciences Soars 7.37% in After-Hours Trading on Q2 Earnings Beat and Reaffirmed Guidance
Stock Track
Jul 24
Edwards Lifesciences shares surged 7.37% in after-hours trading on Thursday, following the release of second-quarter financial results that handily beat Wall Street estimates and a reaffirmed full-year profit outlook.
The company reported adjusted earnings per share of $0.78, exceeding the consensus estimate of $0.74. Quarterly sales came in at $1.741 billion, also ahead of the $1.700 billion analysts had expected. Both top and bottom lines showed double-digit growth compared to the same period last year.
Investor sentiment was further bolstered as the company reaffirmed its 2026 adjusted EPS guidance of $2.95 to $3.05, signaling confidence in its business trajectory despite macroeconomic uncertainties.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.